PositoAI/ IN/ Lyka Labs Limited

Lyka Labs Limited

NSE: LYKALABS · Healthcare

Positivity Index

#3,962 / 6,775

Global

#1,915 / 2,401

India

Positivity Score

20,089

Rank→

Overview Go Deep Penta Pattern Funda Actions News For this company Histo

PosiRed: no active red flags

Lyka Labs Limited — Overview & Financial Snapshot

Lyka Labs Limited (NSE: LYKALABS) is a Healthcare company, ranked #3,962 of 6,775 companies globally and #1,915 of 2,401 in India on PositoAI, with a Positivity Score of 20,089. Its market capitalisation is ₹292.80 Cr, P/E ratio is -32.4 and P/B ratio is 3.17. It has no active red flags (PosiRed) or yellow flags (PosiYellow) on record.

For financial statements, ratio trends and score history, Go Deep →

Top-ranked Healthcare companies

#48 Balaxi Pharmaceuticals Limited 25,746 #58 Fabtech Technologies Limited 25,664 #84 Shalby Limited 25,504 #93 Par Drugs and Chemicals Limited 25,485 #110 Dishman Carbogen Amcis Limited 25,370

Dividends, bonus & splits

Merger - Demerger — 100:23 04 Jun 2026

Lyka Labs Limited dividend history & all corporate actions →

OpenAI is reading recent news...

Lyka Labs Limited, a pharmaceutical company, develops, manufactures, and markets pharmaceutical formulations for human and animal healthcare in India and internationally. It offers injectable critical care solutions, anti-infectives, antifungals, anti-ulcer therapies, oncology support, cardiovascular therapies, and women's healthcare solutions such as gonadotropins, hormonal therapies, and haematinic formulations. The company also develops pharmaceutical and nutritional solutions for livestock, poultry, equine, and companion animals. In addition, it engages in sterile injectable manufacturing, advanced lyophilization technology, liposomal drug delivery, quality assurance and quality control systems, and stability testing and validation services. The company offers its products in various forms, including lyophilized, liquid, and dry powder injections, as well as ointments, creams, and lotions. It also exports its products. The company was incorporated in 1976 and is based in Mumbai, India.

P/B Ratio 3.17

P/E Ratio -32.4

D/E Ratio 0.54

ROE (calculated) -9.66%

Owes vs Owns ? 0.48× Low ₹0.48 owed for every ₹1 it owns · balance sheet Mar 2026

Dividend Yield 0.00%

Trailing EPS ₹-2.50

Forward EPS —

Beta 0.58

Market Cap ₹292.80 Cr

What these numbers mean →

What does Lyka Labs Limited do?

What is Lyka Labs Limited's P/E and P/B ratio?

Lyka Labs Limited has a P/E ratio of -32.4 and a P/B ratio of 3.17.

What is Lyka Labs Limited's debt-to-equity ratio?

Lyka Labs Limited has a debt-to-equity ratio of 0.54.

How much does Lyka Labs Limited owe compared with what it owns?

Lyka Labs Limited owes ₹0.48 for every ₹1 it owns (balance sheet Mar 2026), which is low.

What is Lyka Labs Limited's Positivity rank?

Lyka Labs Limited is ranked #3,962 of 6,775 companies globally and #1,915 of 2,401 in India on PositoAI, with a Positivity Score of 20,089.

Does Lyka Labs Limited have any SEBI orders, red flags (PosiRed) or yellow flags (PosiYellow)?

No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Lyka Labs Limited.

Where can I read the latest news about Lyka Labs Limited?

Recent headlines about Lyka Labs Limited from the last 30 days, with links to the original articles, are on its News page on PositoAI.

Does Lyka Labs Limited have a PositoAI PosiShot or QR code?

Yes. A dated PosiShot of Lyka Labs Limited's current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.

0 / 1000

🔒 Private — stored only in this browser, never sent to PositoAI. Clear anytime in Settings.